Obstetric and Gynaecology, Kilimanjaro Christian Medical Centre, Moshi, Kilimanjaro, Tanzania
Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
Sex Transm Infect. 2021 Feb;97(1):56-62. doi: 10.1136/sextrans-2019-054263. Epub 2020 Apr 8.
The objective of the present study was to assess the prevalence and type-specific distribution of cervical high-risk (HR) human papillomavirus (HPV) among women with normal and abnormal cytology, and to describe risk factors for HR HPV among HIV-positive and HIV-negative women in Tanzania.
A cross-sectional study was conducted in existing cervical cancer screening clinics in Kilimanjaro and Dar es Salaam. Cervical specimens were obtained from women aged 25-60 years. Samples were shipped to Denmark for cytological examination, and to Germany for HR HPV testing (using Hybrid Capture 2) and genotyping (using LiPaExtra). Risk factors associated with HPV were assessed by multivariable logistic regression analysis.
Altogether, 4080 women were recruited with 3416 women contributing data for the present paper, including 609 HIV-positive women and 2807 HIV-negative women. The overall HR HPV prevalence was 18.9%, whereas the HR HPV prevalence in women with high-grade squamous intraepithelial lesions (HSILs) was 92.7%. Among HPV-positive women with HSIL, HPV16 (32.5%) and HPV58 (19.3%) were the the most common types followed by HPV18 (16.7%) and HPV52 (16.7%). Factors associated with HR HPV included younger age, increasing number of partners and early age at first intercourse. Similar risk factors were found among HIV-positive and HIV-negative women. In addition, among HIV-positive women, those with CD4 counts <200 cells/mm had an increased risk of HR HPV (OR 2.2; 95% CI 1.2 to 4.8) compared with individuals with CD4 count ≥500 cells/mm.
Given the HPV distribution among Tanzanian women, the current HPV vaccination in Tanzania using quadrivalent vaccine may be considered replaced by the nonavalent vaccine in the future. In addition, appropriate antiretroviral treatment management including monitoring of viremia may decrease the burden of HR HPV in HIV-positive women.
本研究旨在评估细胞学正常和异常的女性中宫颈高危(HR)人乳头瘤病毒(HPV)的流行率和型别分布,并描述坦桑尼亚 HIV 阳性和 HIV 阴性女性中 HR HPV 的危险因素。
在乞力马扎罗和达累斯萨拉姆现有的宫颈癌筛查诊所进行了一项横断面研究。采集 25-60 岁女性的宫颈标本。样本被运送到丹麦进行细胞学检查,以及德国进行 HR HPV 检测(使用杂交捕获 2)和基因分型(使用 LiPaExtra)。通过多变量逻辑回归分析评估与 HPV 相关的危险因素。
共招募了 4080 名女性,其中 3416 名女性提供了本论文的数据,包括 609 名 HIV 阳性女性和 2807 名 HIV 阴性女性。总的 HR HPV 流行率为 18.9%,而高级别鳞状上皮内病变(HSIL)女性的 HR HPV 流行率为 92.7%。在 HPV 阳性且患有 HSIL 的女性中,HPV16(32.5%)和 HPV58(19.3%)是最常见的类型,其次是 HPV18(16.7%)和 HPV52(16.7%)。与 HR HPV 相关的因素包括年龄较小、性伴侣数量增加和初次性交年龄较小。在 HIV 阳性和 HIV 阴性女性中也发现了类似的危险因素。此外,在 HIV 阳性女性中,与 CD4 计数≥500 个细胞/mm 的个体相比,CD4 计数<200 个细胞/mm 的个体发生 HR HPV 的风险增加(OR 2.2;95%CI 1.2 至 4.8)。
鉴于坦桑尼亚女性的 HPV 分布情况,目前在坦桑尼亚使用四价疫苗进行 HPV 疫苗接种可能会被考虑在未来用九价疫苗取代。此外,适当的抗逆转录病毒治疗管理,包括监测病毒血症,可能会降低 HIV 阳性女性中 HR HPV 的负担。